EXTRAPHARM TILFF
ActiveSummary
EXTRAPHARM TILFF has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €320,924 and a net result of -€72,704. Equity is growing by about 20% per year across the filed financial years. Its solvency ranks better than 27% of 12,724 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
8th largest company by total assets in Esneux, Wholesale and retail trade sector1 site
Size
≈ €640,000turnover 2025, estimated
- Staff
- 1.3 FTE
- Equity
- €320,924
- Loss
- -€72,704
Turnover estimated from the gross margin
Structure
- Largest shareholder
- VSF MANAGEMENT · 25%
- Board
- 4 members
2025 accounts 45 days early3 of 6 deeds summarised
Why 65raises risk1 change of registered office in 24 months1 of the last 3 latelowers riskFigures for financial year 2025 (filed 16-06-2026)Size: 1.3 FTE, total assets €1.9mShow the evidence
Checked score
Score 2025
65
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 31% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency
42-58
equity 16.8% of total assets
Liquidity
50-12
short-term debt 24.1% · cash 6.8%
Profitability
21-71
return on assets -3.8%
Bankruptcy probability, 12 months
1.1%
Low
0%0.5%1.5%4%10%≥ 25%
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.2%
12-2024: 0.2%● unchanged vs 11-2024
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025lowest value
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.3%▲ +0.1 percentage points vs 06-2025
08-2025: 0.5%▲ +0.2 percentage points vs 07-2025
09-2025: 0.6%▲ +0.1 percentage points vs 08-2025
10-2025: 0.9%▲ +0.3 percentage points vs 09-2025
11-2025: 0.9%● unchanged vs 10-2025
12-2025: 0.4%▼ -0.5 percentage points vs 11-2025
01-2026: 0.4%● unchanged vs 12-2025
02-2026: 0.4%● unchanged vs 01-2026
03-2026: 0.4%● unchanged vs 02-2026
04-2026: 0.4%● unchanged vs 03-2026
05-2026: 0.4%● unchanged vs 04-2026
06-2026: 0.3%▼ -0.1 percentage points vs 05-2026
07-2026: 0.6%▲ +0.3 percentage points vs 06-2026
08-2026: 0.6%● unchanged vs 07-2026
09-2026: 1.1%▲ +0.5 percentage points vs 08-2026highest value
10-2026: 1.1%● unchanged vs 09-2026highest value
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.83, compared with 3.4 in 2024, below 1; short-term debt: 24.1% and cash: 6.8% of total assets), and 83.2% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 33% on solvency, 50% on liquidity, 22% on profitability and 21% on growth.
The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-06-2026, 45 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
45 days early
2024
116 days late
2023
27 days early
2022
31 days late
2021
16 days early
2020
15 days early
2019
18 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 4 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 15 July (4 of the last 5 filed years within 47 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
- Appointment: EL MANAGEMENT (director)Permanent representative: LAUSBERG Elise ·…
- Annual accounts filedfinancial year 2025 · abbreviated…
- Weakest financial yearnet -€72,704
Financials · financial year 2025, abbreviated format
Turnover
€0
EBIT margin
Not included in this filing
Net result
-€72,704
2024 · €93,660
Working capital
-€76,646
2024 · €225,784
Trend over the years
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result turns negative in 2025: a loss of €36,979 after €155,147 in 2024, the lowest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result-€0.04m
2025
Net result-€0.07m
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€1.9m
2025
Equity€0.3m
2025
Debt€1.6m
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital-€0.08m
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)-3.8%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency16.8%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio0.83
2025
Average staff in full-time equivalents (FTE).
Staff (FTE)1.3
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Turnover€0
Operating result€0.04m-€0.04m▲ 6.8%€0.05m▲ 25.8%€0.02m▼ 65.6%€0.2m▲ 841%€0.1m▼ 45.5%€0.2m▲ 60.6%-€0.04m
Net result€0.01m-€0.02m▲ 62.3%€0.04mwithin the sector's middle half▲ 70.7%€0.009mwithin the sector's middle half▼ 75.3%€0.1mabove the sector's middle half▲ 15×€0.05mwithin the sector's middle half▼ 60.0%€0.09mwithin the sector's middle half▲ 72.6%-€0.07mbelow the sector's middle half
Equity€0.1m-€0.1m▲ 16.4%€0.2mwithin the sector's middle half▲ 22.2%€0.2mwithin the sector's middle half▼ 7.6%€0.3mwithin the sector's middle half▲ 79.4%€0.3mwithin the sector's middle half▲ 5.1%€0.4mwithin the sector's middle half▲ 24.6%€0.3mwithin the sector's middle half▼ 18.5%
Total assets€0.5m-€0.5m▲ 0.2%€0.5mwithin the sector's middle half▼ 5.1%€0.5mwithin the sector's middle half▲ 0.3%€0.7mwithin the sector's middle half▲ 46.9%€0.7mwithin the sector's middle half▲ 5.8%€0.5mwithin the sector's middle half▼ 30.7%€1.9mabove the sector's middle half▲ 273%
Debt€0.4m-€0.4m▼ 5.4%€0.3m▼ 16.6%€0.3m▲ 5.1%€0.4m▲ 29.4%€0.4m▲ 6.3%€0.1m▼ 72.1%€1.6m▲ 13×
Working capital-€0.1m--€0.1m▲ 29.6%-€0.05mbelow the sector's middle half▲ 50.3%-€0.1mbelow the sector's middle half▼ 133%-€0.2mbelow the sector's middle half▼ 45.0%-€0.1mbelow the sector's middle half▲ 35.8%€0.2mwithin the sector's middle half-€0.08mbelow the sector's middle half
Solvency25.6%-29.8%▲ 4.1pp38.3%within the sector's middle half▲ 8.5pp35.3%within the sector's middle half▼ 3.0pp43.1%within the sector's middle half▲ 7.8pp42.8%within the sector's middle half▼ 0.3pp77.0%above the sector's middle half▲ 34.2pp16.8%within the sector's middle half▼ 60.2pp
Current ratio0.59-0.70▲ 0.110.82below the sector's middle half▲ 0.120.60below the sector's middle half▼ 0.220.56below the sector's middle half▼ 0.050.73below the sector's middle half▲ 0.173.40above the sector's middle half▲ 2.670.83below the sector's middle half▼ 2.57
Return on assets (ROA)2.6%-4.2%▲ 1.6pp7.5%within the sector's middle half▲ 3.3pp1.9%within the sector's middle half▼ 5.7pp19.4%above the sector's middle half▲ 17.6pp7.4%within the sector's middle half▼ 12.1pp18.3%above the sector's middle half▲ 11.0pp-3.8%below the sector's middle half▼ 22.1pp
Staff (FTE)2.6-2▼ 23.1%1.7below the sector's middle half▼ 15.0%1.7below the sector's middle half=1.7below the sector's middle half=1.7below the sector's middle half=1.7below the sector's middle half=1.3below the sector's middle half▼ 23.5%
above
within
below
the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.9m
Fixed assets
€1.5m ▲ 696%
Current assets
€382,335 ▲ 19.5%
Equity and liabilities €1.9m
Equity
€320,924 ▼ 18.5%
Debt
€1.6m ▲ 13×
Debt's share of the balance-sheet total rises from 23.0% to 83.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€31,273▼
2024 · €186,559
Cash flow
-€4,451▼
2024 · €125,072
Quick ratio
0.56▼
2024 · 2.58
Debt to equity
4.94▲
2024 · 0.30
ROE
-22.7%▼
2024 · 23.8%
Interest coverage
0.80▼
2024 · 6.23
Debt ≤ 1 year
€458,982▲
2024 · €94,058
Debt > 1 year
€1.1m
Income taxes
€0▼
2024 · €34,137
Staff costs
€87,910▼
2024 · €98,678
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 2,166 companies that looked in July 2024 the way this one looks now, 2.5% went bankrupt within 24 months and 94.2% are still going.
- Micro
- 10 to 20 years old
- solvency 10 to 30%
- a small loss
2.5%
went bankrupt
3.0%
stopped otherwise
94.2%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 1.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 2,166 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Turnover70 | - | - | - | - | - | - | €0 | - | - |
| Non-recurring operating income76A | - | - | - | €2,783 | - | €575 | €575 | €0 | ▼ 100% |
| Goods, raw materials, services and sundry goods60/61 | - | - | - | - | - | - | €0 | - | - |
| Remuneration, social security and pensions62 | - | - | - | €81,448 | €86,515 | €97,007 | €98,678 | €87,910 | ▼ 10.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €27,688 | €27,828 | €22,036 | €17,039 | €32,055 | €48,795 | €31,412 | €68,253 | ▲ 117% |
| Other operating charges640/8 | - | - | - | €3,766 | €3,669 | €3,564 | €7,124 | €11,781 | ▲ 65.4% |
| Non-recurring operating charges66A | - | - | - | €4,787 | - | €100 | €100 | €6,069 | ▲ 61× |
| Gross operating margin9900 | €161,224 | €165,449 | €160,771 | €125,875 | €299,573 | €246,059 | €292,461 | €137,033 | ▼ 53.1% |
| Operating profit (loss)9901 | €40,722 | €43,511 | €54,757 | €18,836 | €177,334 | €96,593 | €155,147 | -€36,979 | - |
| Financial income75/76B | - | - | - | €1,938 | €130 | €112 | €2,597 | €3,214 | ▲ 23.8% |
| Recurring financial income75 | €148 | €211 | €505 | €1,938 | €130 | €112 | €2,597 | €3,214 | ▲ 23.8% |
| Financial charges65/66B | - | - | - | €11,295 | €12,465 | €19,821 | €29,946 | €38,939 | ▲ 30.0% |
| Recurring financial charges65 | €19,120 | €14,374 | €11,494 | €11,295 | €12,465 | €19,821 | €29,946 | €38,939 | ▲ 30.0% |
| Profit (loss) for the period before taxes9903 | €21,750 | €29,349 | €43,768 | €9,479 | €164,998 | €76,884 | €127,797 | -€72,704 | - |
| Transfer from deferred taxes780 | - | - | - | €58 | €499 | - | - | - | - |
| Transfer to deferred taxes680 | - | - | - | €557 | - | - | - | - | - |
| Income taxes67/77 | €8,861 | €8,429 | €8,069 | €146 | €29,996 | €22,631 | €34,137 | €0 | ▼ 100% |
| Profit (loss) for the period9904 | €12,889 | €20,919 | €35,700 | €8,835 | €135,501 | €54,253 | €93,660 | -€72,704 | - |
| Transfer from tax-exempt reserves789 | - | - | - | €174 | €2,052 | - | - | - | - |
| Transfer to tax-exempt reserves689 | - | - | - | €2,226 | - | - | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €12,889 | €20,919 | €35,700 | €6,783 | €137,553 | €54,253 | €93,660 | -€72,704 | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €0.5m | €0.5m | €0.5m | €0.5m | €0.7m | €0.7m | €0.5m | €1.9m | ▲ 273% |
| Fixed assets21/28 | €0.3m | €0.3m | €0.2m | €0.3m | €0.5m | €0.4m | €0.2m | €1.5m | ▲ 696% |
| Intangible fixed assets21 | €0.02m | €0.005m | - | - | - | - | - | - | - |
| Tangible fixed assets22/27 | €0.3m | €0.3m | €0.2m | €0.3m | €0.5m | €0.4m | €0.2m | €1.5m | ▲ 699% |
| Land and buildings22 | - | - | - | €0.2m | €0.2m | €0.2m | €0 | €1.3m | - |
| Plant, machinery and equipment23 | - | - | - | €0.07m | €0.3m | €0.2m | €0.2m | €0.2m | ▼ 13.2% |
| Furniture and vehicles24 | - | - | - | €0.02m | €0.02m | €0.009m | €0.003m | €0.01m | ▲ 325% |
| Assets under construction and advance payments27 | - | - | - | - | €0.002m | €0.003m | €0 | - | - |
| Financial fixed assets28 | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | = |
| Current assets29/58 | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | €0.3m | €0.3m | €0.4m | ▲ 19.5% |
| Stocks and contracts in progress3 | €0.1m | €0.1m | €0.1m | €0.05m | €0.08m | €0.1m | €0.08m | €0.1m | ▲ 64.5% |
| Stocks30/36 | - | - | - | €0.05m | €0.08m | €0.1m | €0.08m | €0.1m | ▲ 64.5% |
| Amounts receivable within one year40/41 | €0.04m | €0.05m | €0.06m | €0.07m | €0.07m | €0.07m | €0.2m | €0.1m | ▼ 32.5% |
| Trade receivables40 | - | - | - | €0.05m | €0.07m | €0.07m | €0.06m | €0.1m | ▲ 77.2% |
| Other amounts receivable41 | - | - | - | €0.02m | €0.008m | €136 | €0.1m | €0.01m | ▼ 90.4% |
| Current investments50/53 | - | - | - | - | - | - | - | €0 | - |
| Cash at bank and in hand54/58 | €0.07m | €0.08m | €0.05m | €0.06m | €0.05m | €0.1m | €0.07m | €0.1m | ▲ 81.2% |
| Deferred charges and accrued income490/1 | - | - | - | €0.006m | €0.003m | €0.008m | €0.001m | €0.01m | ▲ 13× |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €0.5m | €0.5m | €0.5m | €0.5m | €0.7m | €0.7m | €0.5m | €1.9m | ▲ 273% |
| Equity10/15 | €0.1m | €0.1m | €0.2m | €0.2m | €0.3m | €0.3m | €0.4m | €0.3m | ▼ 18.5% |
| Contributions10/11 | €0.02m | €0.02m | - | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | = |
| Reserves13 | €0.09m | €0.09m | €0.09m | €0.07m | €0.07m | €0.03m | €0.02m | €0.4m | ▲ 20× |
| Non-distributable reserves130/1 | - | - | - | €0.002m | €0.002m | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.002m | €0.002m | - | - | - | - |
| Tax-exempt reserves132 | - | - | - | €0.002m | - | - | - | - | - |
| Distributable reserves133 | - | - | - | €0.07m | €0.07m | €0.03m | €0.02m | €0.4m | ▲ 20× |
| Profit (loss) carried forward14 | €0.02m | €0.04m | €0.07m | €0.08m | €0.2m | €0.3m | €0.4m | -€0.07m | - |
| Provisions and deferred taxes16 | - | - | - | €499 | - | - | - | - | - |
| Deferred taxes168 | - | - | - | €499 | - | - | - | - | - |
| Amounts payable17/49 | €0.4m | €0.4m | €0.3m | €0.3m | €0.4m | €0.4m | €0.1m | €1.6m | ▲ 13× |
| Amounts payable after more than one year17 | - | - | - | - | - | - | - | €1.1m | - |
| Financial debts170/4 | - | - | - | - | - | - | - | €1.1m | - |
| Amounts payable within one year42/48 | €0.4m | €0.3m | €0.3m | €0.3m | €0.4m | €0.4m | €0.09m | €0.5m | ▲ 388% |
| Current portion of amounts payable after more than one year42 | - | - | - | - | - | - | - | €0.04m | - |
| Financial debts43 | - | - | - | €0.002m | - | - | - | €0.06m | - |
| Other loans439 | - | - | - | €0.002m | - | - | - | €0.06m | - |
| Trade debts44 | €0.04m | €0.05m | €0.04m | €0.06m | €0.05m | €0.04m | €0.07m | €0.2m | ▲ 237% |
| Suppliers440/4 | - | - | - | €0.06m | €0.05m | €0.04m | €0.07m | €0.2m | ▲ 237% |
| Taxes, remuneration and social security45 | - | - | - | €0.02m | €0.03m | €0.04m | €0.03m | €0.03m | ▲ 1.0% |
| Taxes450/3 | - | - | - | €0.005m | €0.02m | €0.03m | €0.02m | €0.01m | ▼ 52.7% |
| Remuneration and social security454/9 | - | - | - | €0.01m | €0.01m | €0.01m | €0.003m | €0.02m | ▲ 436% |
| Other amounts payable47/48 | - | - | - | €0.2m | €0.3m | €0.3m | €0 | €0.1m | - |
| Accrued charges and deferred income492/3 | - | - | - | €0.009m | €0.01m | €0.02m | €0.02m | €0.004m | ▼ 83.6% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.01m | €0.02m | €0.04m | €0.009m | €0.1m | €0.05m | €0.09m | -€0.07m | - |
| + Depreciation and write-downs630 | €0.03m | €0.03m | €0.02m | €0.02m | €0.03m | €0.05m | €0.03m | €0.07m | ▲ 117% |
| Operating cash flow (approximation) | €0.04m | €0.05m | €0.06m | €0.03m | €0.2m | €0.1m | €0.1m | -€0.004m | - |
| Investment in fixed assets (approximation) | - | -€0.001m | -€0.001m | -€0.07m | -€0.2m | -€0.01m | €0.2m | -€1.4m | - |
| Change in cash | - | €0.004m | -€0.02m | €0.008m | -€0.006m | €0.06m | -€0.04m | €0.06m | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 15 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 16-06-2026 | 2026-00167567 |
| 31-12-2024 | full format | 24-11-2025 | 2025-00569797 |
| 31-12-2023 | full format | 04-07-2024 | 2024-00210218 |
| 31-12-2022 | full format | 31-08-2023 | 2023-00417909 |
| 31-12-2021 | full format | 15-07-2022 | 2022-20190470 |
| 31-12-2020 | full format | 16-07-2021 | 2021-36800173 |
| 31-12-2019 | full format | 13-07-2020 | 2020-29400446 |
| 31-12-2018 | full format | 18-06-2019 | 2019-19600165 |
| 31-12-2017 | full format | 03-07-2018 | 2018-27900296 |
| 31-12-2016 | full format | 09-06-2017 | 2017-16200088 |
Similar companies · same sector, comparable size
Apotheek Debruyne Klaas
BE 0506.778.280
Middelkerke · equity €320,957
Pharmacie Elodie TRINTELER
BE 0862.526.275
Tournai · equity €320,993
APOTHEEK BOSEIND
BE 0479.593.140
Pelt · equity €320,814
Pharmaplus Detimmerman
BE 0677.508.475
Tournai · equity €321,039
LA PHARMACIE DE VRIESE
BE 0432.814.988
Nivelles · equity €320,772
Of the 5,204 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,907. 3,495 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Directors
4 directors, last change in 2026
Board 4
SAARBACH DINO SRL
CurrentDirector · since 01-02-2025 · Legal entity · permanent representative: Saarbach Dino
VSF MANAGEMENT SRL
CurrentDirector · since 01-02-2025 · Legal entity · permanent representative: Van Sull François
EL MANAGEMENT
CurrentDirector (not named in the articles) · since 28-08-2026 · Private limited company · permanent representative: LAUSBERG Elise
-
CurrentDirector (not named in the articles) · since 11-01-2024 · from a recent deed
Permanent representatives 3
Saarbach Dino
CurrentPermanent representative · since 01-02-2025 · for SAARBACH DINO SRL
Van Sull François
CurrentPermanent representative · since 01-02-2025 · for VSF MANAGEMENT SRL
LAUSBERG Elise
CurrentPermanent representative · since 28-08-2026 · for EL MANAGEMENT
"From a recent act": read from a Gazette act not yet processed into our list of directors.
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
3 of this company's 6 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
5 people since 2024, 4 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| -from an act |
|
| SAARBACH DINO SRL |
|
| VSF MANAGEMENT SRL |
|
| EL MANAGEMENT |
|
| SONNET Béatrice |
|
Owners and capital
Owners
1 ownerOwners 1
-
25%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
Capital over the years
- 11-01-2024 Converted to unavailable equity · €20,460
Group and network
Connections & network
4 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-08
Gazette deed
Appointment: EL MANAGEMENT (director)Permanent representative: LAUSBERG Elise · Name change · Registered-office move7 facts ▸
Gazette deed
Appointment: EL MANAGEMENT (director)
Permanent representative: LAUSBERG Elise · Name change · Registered-office move7 facts ▸
- General meeting, “assemblée générale extraordinaire des actionnaires” (deed in French)
- Name change, EXTRAPHARM TILFF
- Registered-office move, Avenue Laboulle 17,4130 Esneux
- Power of attorney, Jean-Philippe GILLAIN
- Power of attorney
- Director appointment, EL MANAGEMENT (director (not named in the articles))
- Permanent representative, LAUSBERG Elise
16-06
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Weakest financial yearnet -€72,704
Net result drops to -€72,704, the lowest in the series.
24-11
NBB filing
Annual accounts filed
financial year 2024 · full format · 116 days late
19-03
Gazette deed
Resignation: SONNET Béatrice (director)Appointments: VSF MANAGEMENT SRL (director) and SAARBACH DINO SRL (director) · Permanent representatives: Van Sull François and Saarbach Dino7 facts ▸
Gazette deed
Resignation: SONNET Béatrice (director)
Appointments: VSF MANAGEMENT SRL (director) and SAARBACH DINO SRL (director) · Permanent representatives: Van Sull François and Saarbach Dino7 facts ▸
- General meeting, 01-02-2025
- Director resignation, SONNET Béatrice (director)
- Director appointment, VSF MANAGEMENT SRL (director)
- Board meeting, 30-01-2025 (2 times)
- Permanent representative, Van Sull François (director)
- Director appointment, SAARBACH DINO SRL (director)
- Permanent representative, Saarbach Dino (director)
2024
31-12
Financial
Liquidity more than quadruplescurrent ratio 3.40
Current ratio from 0.73 to 3.40; short-term debt falls from €404,411 to €94,058.
04-07
NBB filing
Annual accounts filed
financial year 2023 · full format
11-01
Gazette deed
Resignation: - (manager)Appointment: - (director) · Registered office clause · Amendment of the articles9 facts ▸
Gazette deed
Resignation: - (manager)
Appointment: - (director) · Registered office clause · Amendment of the articles9 facts ▸
- Registered office clause, “4130 Esneux,Avenue Laboulle 22, Sixième résolution” (deed in French)
- Other provision, “unanimité des décisions, CLOTURE” (deed in French)
- General meeting, 14-12-2023
- Amendment of the articles (2 times)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Other provision, “suppression compte capitaux propres statutairement indisponible, supprimer compte et rendre fonds disponibles pour distribution” (deed in French)
- Director resignation, - (manager)
- Director appointment, - (director (not named in the articles))
- Director discharge, -
2023
31-08
NBB filing
Annual accounts filed
financial year 2022 · full format · 31 days late
2022
31-12
Financial
Highest result from 2018 to 2025net €135,501 ▲1,434%
Operating result €177,334, net result €135,501, both a record.
31-12
Financial
Equity above €200,000equity €300,574 ▲79.4%
A profit in every financial year since 2018 builds equity to €300,574.
15-07
NBB filing
Annual accounts filed
financial year 2021 · full format
Show earlier events
2021
16-07
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
31-12
Financial
Equity above €150,000equity €181,412 ▲22.2%
A profit in every financial year since 2018 builds equity to €181,412.
13-07
NBB filing
Annual accounts filed
financial year 2019 · full format
2019
18-06
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
03-07
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
09-06
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 15 annual accounts filed, the latest 10 are here; all 15 are under Financials.
3 of 6 deeds read
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 3 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Register details
Identification
Legal formPrivate limited company
Founded01-07-2010
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0827434447
Also
9925:BE0827434447
Registered
09-07-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Food safety, FASFC
1 siteEsneuxunit no. 2.189.683.245
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Esneux · 1 establishment unit since 2010
Ground area
1,979 m²
Building footprint
1,073 m²
Building volume
3,970 m³
2 parcels, Wallonia · tallest building 8.2 m. Linked by address, not a title deed.
1 establishment unit
PHARMACIE SONNET
since 2010unit no. 2.189.683.245
2 parcels
Wallonia
2
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 62101D0139/00L000 | Wallonia | 1,592 m² | 1 · 959 m² | 8.2 m · 1 |
| 62101D0131/00R000 | Wallonia | 387 m² | 1 · 114 m² | - |
How the parcels are linked
Good to know
Both parcels match the address exactly.
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “L'achat,la vente,la prise en location,l'exploitation sous quelque forme que ce soit,et la location d'officines pharmaceutiques; La société…” (deed in French)
6 activities (deed in French)
- L'achat,la vente,la prise en location,l'exploitation sous quelque forme que ce soit,et la location d'officines pharmaceutiques.
- La société peut en outre participer à la création et au développement d'entreprises industrielles,commerciales,financières ou immobilières destinées ou liées au secteur pharmaceutique au sens large,ou utiles aux sociétés du groupe dont elle fait partie,et dans la mesure de la conformité de chaque prise de participation ou opération de cet ordre avec toutes dispositions légales ou et réglementaires.
- Elle pourra leur apporter tout concours sous la forme jugée la plus appropriée,participation au capital,prêts,financement,garanties,etc.
- La société pourra dans ce cadre accomplir toute activité de gestion,d'administration,de direction et d'organisation.
- La société pourra assurer la gestion journalière et la représentation dans les opérations relevant de cette gestion,au sens de l'article 525 du Code (des sociétés commerciales),des affaires au profit des tiers et pour leur compte.
- La société pourra accomplir toutes opérations industrielles,financières,commerciales ou civiles,ayant un rapport direct ou indirect avec son objet,et s'intéresser de toutes manières dans toutes sociétés ou entreprises dont les activités seraient de nature à favoriser la réalisation de son objet social et notamment sans que la disposition qui suit ne soit limitative : acquérir,prendre ou donner à bail,aliéner tous immeubles,brevets ou licences,acquérir,créer ou céder toutes marques ou procédés de construction.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- PHARMACIE SONNET
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- One provision in the deed
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Organe d'administration, un ou plusieurs administrateurs,personnes physiques ou morales,actionnaires ou non” (deed in French)